22 research outputs found
Recommended from our members
Hydrogels for delivery of therapeutic compounds
In some aspects, methacrylate co-polymers crosslinked with an enzymatically cleavable peptide linker are provided and may be used for the oral delivery of a therapeutic. The peptide linker may be cleavable by an enzyme in the small intestine and may allow for the delivery of a therapeutic protein or nucleic acid to the small intestine. Also provided are methods of using the polymers for the treatment of a disease.Board of Regents, University of Texas Syste
Recommended from our members
Herpesviral ICP0 Protein Promotes Two Waves of Heterochromatin Removal on an Early Viral Promoter during Lytic Infection
ABSTRACT Herpesviruses must contend with host cell epigenetic silencing responses acting on their genomes upon entry into the host cell nucleus. In this study, we confirmed that unchromatinized herpes simplex virus 1 (HSV-1) genomes enter primary human foreskin fibroblasts and are rapidly subjected to assembly of nucleosomes and association with repressive heterochromatin modifications such as histone 3 (H3) lysine 9-trimethylation (H3K9me3) and lysine 27-trimethylation (H3K27me3) during the first 1 to 2 h postinfection. Kinetic analysis of the modulation of nucleosomes and heterochromatin modifications over the course of lytic infection demonstrates a progressive removal that coincided with initiation of viral gene expression. We obtained evidence for three phases of heterochromatin removal from an early gene promoter: an initial removal of histones and heterochromatin not dependent on ICP0, a second ICP0-dependent round of removal of H3K9me3 that is independent of viral DNA synthesis, and a third phase of H3K27me3 removal that is dependent on ICP0 and viral DNA synthesis. The presence of ICP0 in transfected cells is also sufficient to promote removal of histones and H3K9me3 modifications of cotransfected genes. Overall, these results show that ICP0 promotes histone removal, a reduction of H3K9me3 modifications, and a later indirect reduction of H3K27me3 modifications following viral early gene expression and DNA synthesis. Therefore, HSV ICP0 promotes the reversal of host epigenetic silencing mechanisms by several mechanisms
HSV-1 Remodels Host Telomeres to Facilitate Viral Replication
SummaryTelomeres protect the ends of cellular chromosomes. We show here that infection with herpes simplex virus 1 (HSV-1) results in chromosomal structural aberrations at telomeres and the accumulation of telomere dysfunction-induced DNA damage foci (TIFs). At the molecular level, HSV-1 induces transcription of telomere repeat-containing RNA (TERRA), followed by the proteolytic degradation of the telomere protein TPP1 and loss of the telomere repeat DNA signal. The HSV-1-encoded E3 ubiquitin ligase ICP0 is required for TERRA transcription and facilitates TPP1 degradation. Small hairpin RNA (shRNA) depletion of TPP1 increases viral replication, indicating that TPP1 inhibits viral replication. Viral replication protein ICP8 forms foci that coincide with telomeric proteins, and ICP8-null virus failed to degrade telomere DNA signal. These findings suggest that HSV-1 reorganizes telomeres to form ICP8-associated prereplication foci and to promote viral genomic replication
Differential Ligand Binding to a Human Cytomegalovirus Chemokine Receptor Determines Cell Type–Specific Motility
While most chemokine receptors fail to cross the chemokine class boundary with respect to the ligands that they bind, the human cytomegalovirus (HCMV)-encoded chemokine receptor US28 binds multiple CC-chemokines and the CX3C-chemokine Fractalkine. US28 binding to CC-chemokines is both necessary and sufficient to induce vascular smooth muscle cell (SMC) migration in response to HCMV infection. However, the function of Fractalkine binding to US28 is unknown. In this report, we demonstrate that Fractalkine binding to US28 not only induces migration of macrophages but also acts to inhibit RANTES-mediated SMC migration. Similarly, RANTES inhibits Fractalkine-mediated US28 migration in macrophages. While US28 binding of both RANTES and Fractalkine activate FAK and ERK-1/2, RANTES signals through Gα12 and Fractalkine through Gαq. These findings represent the first example of differential chemotactic signaling via a multiple chemokine family binding receptor that results in migration of two different cell types. Additionally, the demonstration that US28-mediated chemotaxis is both ligand-specific and cell type–specific has important implications in the role of US28 in HCMV pathogenesis
Enzymatic Biodegradation of Hydrogels for Protein Delivery Targeted to the Small Intestine
Multiresponsive
polyÂ(methacrylic acid-<i>co</i>-<i>N</i>-vinylpyrrolidone)
hydrogels were synthesized with biodegradable
oligopeptide crosslinks. The oligopeptide crosslinks were incorporated
using EDC-NHS zero-length links between the carboxylic acid groups
of the polymer and free primary amines on the peptide. The reaction
of the peptide was confirmed by primary amine assay and IR spectroscopy.
The microgels exhibited pH-responsive swelling as well as enzyme-catalyzed
degradation targeted by trypsin present in the small intestine, as
demonstrated upon incubation with gastrointestinal fluids from rats.
Relative turbidity was used to evaluate enzyme-catalyzed degradation
as a function of time, and initial trypsin concentration controlled
both the degradation mechanism as well as the extent of degradation.
Trypsin activity was effectively extinguished by incubation at 70
°C, and both the microgels and degradation products posed no
cytotoxic effect toward two different cell lines. The microgels demonstrated
pH-dependent loading of the protein insulin for oral delivery to the
small intestine
Recommended from our members
A Herpesviral Lytic Protein Regulates the Structure of Latent Viral Chromatin
ABSTRACT Latent infections by viruses usually involve minimizing viral protein expression so that the host immune system cannot recognize the infected cell through the viral peptides presented on its cell surface. Herpes simplex virus (HSV), for example, is thought to express noncoding RNAs such as latency-associated transcripts (LATs) and microRNAs (miRNAs) as the only abundant viral gene products during latent infection. Here we describe analysis of HSV-1 mutant viruses, providing strong genetic evidence that HSV-infected cell protein 0 (ICP0) is expressed during establishment and/or maintenance of latent infection in murine sensory neurons in vivo. Studies of an ICP0 nonsense mutant virus showed that ICP0 promotes heterochromatin and latent and lytic transcription, arguing that ICP0 is expressed and functional. We propose that ICP0 promotes transcription of LATs during establishment or maintenance of HSV latent infection, much as it promotes lytic gene transcription. This report introduces the new concept that a lytic viral protein can be expressed during latent infection and can serve dual roles to regulate viral chromatin to optimize latent infection in addition to its role in epigenetic regulation during lytic infection. An additional implication of the results is that ICP0 might serve as a target for an antiviral therapeutic acting on lytic and latent infections
Recommended from our members
CCCTC-Binding Factor Acts as a Heterochromatin Barrier on Herpes Simplex Viral Latent Chromatin and Contributes to Poised Latent Infection
ABSTRACT Herpes simplex virus 1 (HSV-1) establishes latent infection in neurons via a variety of epigenetic mechanisms that silence its genome. The cellular CCCTC-binding factor (CTCF) functions as a mediator of transcriptional control and chromatin organization and has binding sites in the HSV-1 genome. We constructed an HSV-1 deletion mutant that lacked a pair of CTCF-binding sites (CTRL2) within the latency-associated transcript (LAT) coding sequences and found that loss of these CTCF-binding sites did not alter lytic replication or levels of establishment of latent infection, but their deletion reduced the ability of the virus to reactivate from latent infection. We also observed increased heterochromatin modifications on viral chromatin over the LAT promoter and intron. We therefore propose that CTCF binding at the CTRL2 sites acts as a chromatin insulator to keep viral chromatin in a form that is poised for reactivation, a state which we call poised latency
Enzyme- and pH-Responsive Microencapsulated Nanogels for Oral Delivery of siRNA to Induce TNF‑α Knockdown in the Intestine
Inflammatory bowel diseases (IBD)
manifest from excessive intestinal
inflammation. Local delivery of siRNA that targets these inflammatory
cytokines would provide a novel treatment approach. Microencapsulated
nanogels are designed and validated as platforms for oral delivery
of siRNA targeting TNF-α, a common clinical target of IBD treatments.
The preferred platform was designed to (i) protect siRNA-loaded nanogels
from the harsh acidic environment of the upper GI tract and (ii) enzymatically
degrade and release the nanogels once the carrier has reached the
intestinal region. This platform consists of microgels composed of
polyÂ(methacrylic acid-<i>co</i>-<i>N</i>-vinyl-2-pyrrolidone)
(PÂ[MAA-<i>co</i>-NVP]) cross-linked with a trypsin-degradable
peptide linker. The PÂ(MAA-<i>co</i>-NVP) backbone is designed
to collapse around and protect encapsulated nanogel from degradation
at the low pH levels seen in the stomach (pH 2–4). At pH levels
of 6–7.5, as typically observed in the intestine, the PÂ(MAA-<i>co</i>-NVP) matrix swells, potentially facilitating diffusion
of intestinal fluid and degradation of the matrix by intestinal enzymes
such as trypsin, thus “freeing” the therapeutic nanogels
for delivery and cellular uptake within the intestine. TNF-α
siRNA-loaded nanogels released from this platform were capable of
inducing potent knockdown of secreted TNF-α levels in murine
macrophages, further validating the potential for this approach to
be used for the treatment of IBD